Clonality of HTLV-2 in Natural Infection
Open Access
- 13 March 2014
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS Pathogens
- Vol. 10 (3) , e1004006
Abstract
Human T-lymphotropic virus type 1 (HTLV-1) and type 2 (HTLV-2) both cause lifelong persistent infections, but differ in their clinical outcomes. HTLV-1 infection causes a chronic or acute T-lymphocytic malignancy in up to 5% of infected individuals whereas HTLV-2 has not been unequivocally linked to a T-cell malignancy. Virus-driven clonal proliferation of infected cells both in vitro and in vivo has been demonstrated in HTLV-1 infection. However, T-cell clonality in HTLV-2 infection has not been rigorously characterized. In this study we used a high-throughput approach in conjunction with flow cytometric sorting to identify and quantify HTLV-2-infected T-cell clones in 28 individuals with natural infection. We show that while genome-wide integration site preferences in vivo were similar to those found in HTLV-1 infection, expansion of HTLV-2-infected clones did not demonstrate the same significant association with the genomic environment of the integrated provirus. The proviral load in HTLV-2 is almost confined to CD8+ T-cells and is composed of a small number of often highly expanded clones. The HTLV-2 load correlated significantly with the degree of dispersion of the clone frequency distribution, which was highly stable over ∼8 years. These results suggest that there are significant differences in the selection forces that control the clonal expansion of virus-infected cells in HTLV-1 and HTLV-2 infection. In addition, our data demonstrate that strong virus-driven proliferation per se does not predispose to malignant transformation in oncoretroviral infections. The two human retroviruses HTLV-1 and HTLV-2 are similar in their structure, replication cycle and the manner through which they spread between and within individuals. They differ in their preferred host T-cell type and in their possible clinical outcomes. HTLV-2 has not been linked with a specific disease, whereas HTLV-1 infection can cause leukemia and profound neuropathology. It is well established that HTLV-1-infected cells undergo clonal expansion in infected individuals, but little is known about clonality in HTLV-2 infection. In this work, we demonstrate that the extent of HTLV-2-infected cell expansion significantly exceeds that of HTLV-1-infected cells in healthy carriers, approximating instead to that observed in patients with HTLV-1-associated leukemia. Furthermore, we show that HTLV-2 characteristically resides in a small number of expanded clones that persist over time, and that the degree of oligoclonality significantly correlates with viral burden in HTLV-2-infected individuals. These results highlight the distinction between in vivo clonal proliferation and malignant transformation, and suggest that the infected cell type may be a more important determinant of clinical outcome in retroviral infections.Keywords
This publication has 55 references indexed in Scilit:
- HTLV-1–infected T cells contain a single integrated provirus in natural infectionBlood, 2012
- Distinct Transformation Tropism Exhibited by Human T Lymphotropic Virus Type 1 (HTLV-1) and HTLV-2 Is the Result of Postinfection T Cell Clonal ExpansionJournal of Virology, 2012
- The host genomic environment of the provirus determines the abundance of HTLV-1–infected T-cell clonesBlood, 2011
- Human T-cell leukemia virus type 1 (HTLV-1) and leukemic transformation: viral infectivity, Tax, HBZ and therapyOncogene, 2010
- Increased All-Cause and Cancer Mortality in HTLV-II InfectionJAIDS Journal of Acquired Immune Deficiency Syndromes, 2010
- Galaxy: A Web‐Based Genome Analysis Tool for ExperimentalistsCurrent Protocols in Molecular Biology, 2010
- Long-term increases in lymphocytes and platelets in human T-lymphotropic virus type II infectionBlood, 2008
- In vivo T lymphocyte dynamics in humans and the impact of human T-lymphotropic virus 1 infectionProceedings of the National Academy of Sciences, 2007
- Human T-Cell Leukemia Virus Type 1 (HTLV-1) and HTLV-2 Use Different Receptor Complexes To Enter T CellsJournal of Virology, 2006
- Modelling the risk of adult T‐cell leukemia/lymphoma in persons infected with human T‐lymphotropic virus type IInternational Journal of Cancer, 1989